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Abstract.  We studied the interaction of MB6A lym- 
phoma and TAM2D2 T  cell hybridoma cells with he- 
patocyte cultures as an in vitro model for in vivo liver 
invasion by these tumor cells. A  monoclonal antibody 
against leukocyte function-associated antigen-1  (LFA-1) 
inhibited adhesion of the tumor cells to the surface of 
hepatocytes and consequently strongly reduced inva- 
sion.  This effect was specific since control antibodies, 
directed against Thy.1  and against T200,  of the same 
isotype, similar affinity,  and comparable binding to 
these cells, did not inhibit adhesion.  This suggests that 
LFA-1 is involved in the formation of liver metastases 
by lymphoma cells. 
TAM2D2 T  cell hybridoma cells were agglutinated 
by anti-LFA-1, but not by control antibodies.  Reduc- 
tion of adhesion was not due to this agglutination 
since monovalent Fab fragments inhibited adhesion as 
well, inhibition was also seen under conditions where 
agglutination  was minimal,  and anti-LFA-1  similarly 
affected adhesion of MB6A lymphoma cells that were 
not agglutinated. 
The two cell types differed in LFA-1 surface density. 
TAM2D2 cells exhibited 400,000 surface LFA-1 mole- 
cules,  10 times more than MB6A cells.  Nevertheless, 
the level of adhesion and the extent of inhibition by 
the anti-LFA-I  antibody were only slightly larger for 
the TAM2D2 cells. 
M 
ETASTATIC lymphoma cells often extensively colo- 
nize the liver (3, 8, 30, 38). Such lymphoma cells 
are highly invasive in cultures of isolated hepato- 
cytes (32).  Remarkably,  normal activated T cells invade he- 
patocyte monolayers similarly as the tumor cells (29). When 
these T ceils are fused with noninvasive and nonmetastatic 
lymphoma cells, the resulting T cell hybridomas are not only 
invasive but also acquire the capacity to metastasize, particu- 
larly to the liver (7, 31). This indicates  that invasiveness  is 
essential for metastasis formation by these cells, and suggests 
that one of the reasons for the high metastatic capacity of cer- 
tain lymphoma cells is that they express the inherent invasive 
machinery of lymphoid cells.  Furthermore,  it implies  that 
cell components involved in interactions  between lympho- 
cytes and tissues may play a role in invasion by lymphoma 
cells.  Presently we report on the involvement  of one such 
component,  the  leucocyte  function-associated  antigen-1 
(LFA-1). 1 
LFA-1 was discovered with an antibody that inhibits killing 
by cytotoxic T cells (5). The antibody does not interfere with 
the  lethal  hit  but rather  with adhesion to the target  cell, 
necessary for efficient killing  (1, 6,  18, 42). It is now clear 
that LFA-1 is involved in multiple adhesion-related  phenom- 
1. Abbreviation  used in this paper: LFA, leukocyte function-associated an- 
tigen. 
ena, mainly among leukocytes (6, 11, 14, 15, 23, 26, 33, 34, 
42) but also in some cases between leukocytes and endothe- 
lial cells (4, 20, 47; for reviews,  17, 19, 43). The initial step 
of invasion into the hepatocyte monolayers is adhesion to the 
upper surface,  and inhibition  of this  step leads to a corre- 
sponding reduction of invasion (22, 28). We now show that 
LFA-1 is involved in adhesion to hepatocytes by both a T cell 
hybridoma and a lymphoma cell line, and is therefore likely 
to be important for the formation of liver metastases by lym- 
phoma cells. 
Materials and Methods 
Tumor Cells 
MB6A lymphosarcoma cells were maintained in ascites in (C57BI×DBA)Ft 
mice as described (30). Metastasis formation in vivo and invasion in hepato- 
cyte cultures in vitro by these cells have p~viously been described in detail 
(8, 30, 32). Generation, properties, and culture of mouse T cell hybridomas 
were reported elsewhere (31). 
Hepatocyte Isolation and Culture 
Rat hepatocytes were isolated as described previously (28). The cells were 
seeded in 16-mm multiwell plates (Primaria; Falcon Labware, Oxnard, CA) 
at 2.5  x  IO  s cells per well in DME (Flow Laboratories, Irvine, Ayeshire, 
Scotland) supplemented with 5 Ixg bovine insulin/ml (Sigma Chemical Co., 
St. Louis, MO). Before seeding, the wells were coated with 5 % newborn 
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washed  twice  with  DME-insulin,  and  cultured  overnight  in  the  same 
medium supplemented with 10%  newborn calf serum. 
Adhesion and Invasion Assays 
Adhesion of tumor cells to hepatocyte cultures was quantitated using tumor 
cells labeled with 5~Cr (100 ~tCi NaStCrO4, 1 mCi/lag Cr; Amersham Inter- 
national, Amersham, UK) per 2  x  107 cells in 100-200 ttl PBS for 1 h at 
37°C, followed by three washes in PBS. After overnight culture, hepatocytes 
were washed once with Earle's balanced salt solution (EBSS; Flow Labora- 
tories). 2-4 x  IO  s labeled tumor cells were incubated for 1 h at 37°C, then 
washed three times with PBS, and sucked dry. Subsequently, 400 Ixl 1 N 
NaOH was added. Radioactivity in the supernatant was counted when the 
hepatocytes were completely detached. To determine the possible effects of 
antibodies, the tumor cells were preincubated for 30 min in 400 pl of a par- 
ticular dilution of antibody in EBSS at 3"/°C and subsequently this 400 pl 
was transferred to a hepatocyte culture well. Control cells were similarly 
incubated with EBSS only. In some experiments the effect of preincubation 
was compared with that in the continued presence of antibody. Cells were 
preincubated as above, centrifuged, and the supernatants removed. The 
pellets were washed with PBS, and either EBSS or the original supernatant 
containing antibody was added, and the suspensions were transferred to he- 
patocyte culture wells. All measurements were done with at least two con- 
trol measurements per plate. 
Adhesion, and in addition invasion, was also quantitated by light micros- 
copy, as described previously (28).  Briefly,  6-8  ×  lOs tumor cells either 
incubated or not with antibody as above, in 400 I~1 EBSS, were added per 
hepatocyte culture in a  16-mm well. The cultures were incubated at 37°C 
fur 4 h, washed once with PBS, fixed with glutaraldehyde, dehydrated, and 
scraped from the dish. The culture fragments were pelleted and embedded 
in Epon (Ladd Research Industries, Burlington, VT). Sections 1 l-n thick 
were stained and observed with a light microscope. Hepatocyte nuclei, tu- 
mor cells adhering to the upper surface of hepatocytes, and infiltrated tumor 
cells were counted. The "interaction index" =  (adherent +  infiltrated tumor 
celis/hepatocyte nuclei) is a measure of total interaction, i.e., adhesion to 
the upper surface plus infiltration; the "infiltration index"  =  (infiltrated 
cells/hepatocyte nuclei) a  measure of invasion. Measurements were per- 
formed in duplicate or triplicate, with at least two controls per plate. 
Antibodies 
The monnclonal antibody used was M17/4 (5), a rat lgG2a, directed against 
mouse LFA-1 ~-chain. The two control antibodies were also rat IgG2a's: 
M1/9.3 (43), directed against mouse "1"200, and M5/49 (43), against mouse 
Thy.l. The antibodies were kindly provided by Dr. E. Martz (University of 
Massachusetts). Hybridoma supernatants were precipitated with 50 % satu- 
rated (NI-h)2SO4, the pellets taken up in 0.9% NaCI  +  10 mM Hepes pH 
7.4,  dialyzed against the same buffer,  and stored at -20"C. Part of the ex- 
periments were done with dilutions of  these preparations. Alternatively, an- 
tibodies were purified from supernatants or precipitates by affinity chro- 
matography  on  Sepharose-coupled goat  anti-rat  Ig  antibodies  (Nordic 
Immunology, Tilburg, The Netherlands). The eluate (0.58%  acetic acid in 
150 mM NaCI) was immediately neutralized with 1 M Tris, concentrated 
in a filter unit (Amicon, Danvers, MA) (cut off: M  =  10,000), and dialyzed 
against PBS.  The concentration was measured spectrophotometrically at 
280 nm using purified rat IgG (Nordic Immunology) as standard. These 
preparations contained pure antibody as determined by SDS-PAGE (not 
shown). 
Preparation of  Fab Fragments 
Fab fragments were prepared essentially according to Rousseaux et al. (36). 
Antibodies were dialyzed against 75 mM NaCI and 2 mM EDTA in 75 mM 
sodium phosphate, pH 7.0 and concentrated to 1-2 mg/ml. Papain was added 
to 1% (wt/wt) of the amount of antibody, cystein to a final concentration of 
0.5  M, and the mixture was incubated overnight at 37°C.  Digestion was 
stopped by the addition of iodoacetamide to a final concentration of 50 mM. 
This preparation was dialyzed against PBS and stored at -20°C. Analysis 
by SDS-PAGE showed that all antibody had been digested (not shown). 
Antibody Binding Assays 
Binding of monoclonal antibodies to tumor cells was assessed indirectly 
using 125I-labeled  anti-rat Ig antibodies (Amersham International). To con- 
ical bottom microtiter plates (Greiner, Niirtingen, Germany) 2-4  x  los 
cells in 100 ~tl culture medium were added per well. The plates were cen- 
trifuged at 2,000 rpm for 2 min, the supernatant was replaced with 100 pl 
of monoclonal antibody diluted in PBS (37°C), and the pellets dispersed. 
The plates were incubated at 37°C for 30 min, centrifuged, washed with ice- 
cold PBS, the,pellets dispersed in 100 ~tl 125I-anti-rat Ig (16 ng/ml PBS, 15 
pCi/~tg), incuba~ on ice for 30 min, centrifuged, washed three times with 
cold PBS, and fi~  ~e pellets were taken up in PBS, transferred to count- 
ing vials, and radioactifity was counted. The radioactivity of the blanks 
(PBS instead of monoclonal antibody), usually less than 200 cpm, was sub- 
tracted from the values obtained. A normal saturation curve was obtained 
and was converted to a straight line by plotting 1/cpm vs.  1/concenttsa.~tion. 
In a few cases, binding was assessed by fluorescence-activated cell so~ng 
analysis, essentially as described previously (31). The obtained saturation 
curves were converted to straight lines by plotting 1/relative  fluorescence 
vs.  1/concentration. 
Binding of anti-LFA-1 antibodies was also assessed directly. 25  Ixg of 
purified anti-LFA-1  antibody was reacted with 1 mCi NaL2~I using chlora- 
mine T,  and separated from free iodide by chromatography on a  Dowex 
column (Bio-Rad Laboratories, Richmond, CA) (12). The assay was per- 
formed in conical bottom microtiter plates as described above. After incuba- 
tion at 37°C for 30 min with the labeled reagent, the plates were centrifuged, 
the supernatants transferred to counting vials, the wells washed once with 
PBS, and the wash fluid combined with the supernatants. The pellets were 
taken up in PBS, transferred to vials, and the radioactivity in both superna- 
tants and pellets was counted. Binding in the presence of a  100-fold excess 
of unlabeled antibody was 2-3 % of that in the absence of competition. The 
amount higher than 1% was considered nonspecific binding and was sub- 
tracted from the obtained values. 
Assay of  Antibody Concentration 
The concentration of antibody in the ammonium sulphate precipitates was 
determined by a solid phase radioimmunoassay. Polyvinyl chloride microti- 
ter plates (type M-24-A; Dynatech, Billingshurst, UK) were coated with 
goat anti-rat IgG (Nordic Immunology), 100 ~g/ml PBS, 100 t.tl per well, 
for 30 rnin at 20°C, and subsequently with 300 pl 0.5 % BSA (Sigma Chemi- 
cal Co.) in PBS for 30 min at 20°C. The well contents were replaced with 
serial dilutions of purified anti-LFA-1 antibody and of antibody samples to 
be measured, and the plates incubated fur 30 rain at 20°C. After washing 
twice with PBS, the wells were exposed to  100  Ixl of 125I-labeled sheep 
anti-rat IgG antibodies (16 ng/ml, 15 ttCi/l~g; Amersham International) for 
30 min at 37°C. After washing twice with PBS, the wells were sucked dry, 
individual  wells  were  cut  from  the  plates,  and  radioactivity  counted. 
Nonspecific binding, as measured in control wells exposed to PBS instead 
of the primary antibody, was subtracted. The saturation curve obtained for 
the purified antibody was converted to a straight line by plotting 1/cpm vs. 
1/concentration.  This  plot was used to determine concentrations in the 
samples. 
Immune Precipitation 
Plasma membrane proteins were labeled by incubation of 3  ×  106 cells 
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Figure 1.  Effect  of anti-LFA-1  antibodies  on  adhesion  of 5~Cr- 
labeled MB6A lymphosarcoma cells to hepatocyte cultures. Values 
obtained in four different experiments are denoted by different sym- 
bols. The values given are percentages of adhesion of control cells 
on the same 24-well plate, and averages of triplicates. Adhesion was 
assessed  1 h  after addition of the cells. 
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Figure 2. Effect of anti-LFA-1 on adhesion of TAM2D2 T cell hy- 
bridoma ceils to hepatocytes in a representative experiment. Given 
are averages of triplicates and standard deviations• The procedure 
was slightly different for the T cell hybrids to minimize agglutina- 
tion,  as described  in the text. 
with  1 mCi Na~251 (Amersham International) in pyrex tubes coated with 
lodogen (Pierce Chemical Co., Rockford, IL)• After 10 min the reaction 
was terminated by suspending the cells in an excess of cold PBS containing 
20 mM KI. Cells were washed twice with cold PBS and stored as pellets 
at -70°C. Labeled ceils (107) were lysed in 1 ml of 0.5% NP-40 in 40 mM 
Tris-HCl,  pH  7.5,  5  mM MgCI2,  1 mM phenylmethylsulfonyl fluoride, 
and 0.002 % soy bean trypsin inhibitor (all reagents from Sigma Chemical 
Co.). After 15 min on ice, cell debris was removed by 10-min centrifugation 
in a minifuge. Lysates were precleared by subsequent incubation with 10 ~tg 
rat IgG (Nordic Immunology) and 80 gg of Sepharose-coupled anti-rat IgG 
antibodies (Nordic Immunology) for 60 and 90 rain,  respectively. After 
overnight incubation of the lysate with anti-LFA-I antibodies (30 rtg/ml), 
the immune complexes were precipitated with 300  gg/ml of Sepharose- 
coupled goat anti-rat IgG antibodies for 2 h• The precipitates were washed 
six times with 0.5 % NP-40 in 50 mM Tris-HC1, pH 7.5, containing 150 mM 
NaCI, 5 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride. SDS-PAGE 
was performed according to Laemmli (16). Precipitates were suspended in 
solubilization buffer, incubated for 5 min at 100°C,  centrifuged to remove 
the Sepharose, and subjected to electrophoresis on 7.5% polyacrylamide 
gels. 
Results 
Effect of  Antibodies on Adhesion of Tumor 
Cells to Hepatocytes 
Monoclonal antibody M17/4 (5), directed against LFA-1, was 
found to inhibit adhesion of MB6A lymphosarcoma cells to 
rat hepatocyte cultures.  As  shown  in  Fig.  1,  adhesion  as 
measured with  radioactively labeled  cells  was  reduced to 
40-60%  of controls, with maximal inhibition down to 200 
ng/ml and half-maximal inhibition at •80  ng/ml. The results 
of four different experiments are depicted to show the extent 
of variability. We used either purified antibody or ammo- 
nium sulphate precipitates with similar results.  Concentra- 
tions of antibody in the latter preparations were measured by 
a  solid phase radioimmunoassay. 
The level of inhibition was independent of the extent of 
adhesion in the control wells, which varied between 15 and 
30%  of added cells. As a control antibody we used M1/9.3 
(43),  also a rat IgG2a, directed against T200.  This antigen 
is present on MB6A cells in similar amounts as LFA-1, and 
the affinity of the antibody is comparable to M17/4  (see be- 
low).  This control antibody did not affect or even slightly 
stimulate adhesion (data not shown). 
Agglutination of T Cell Hybridomas 
A  similar reduction of adhesion was seen with the invasive 
and metastatic T  cell hybridoma TAM2D2  (31).  However, 
quite in contrast to MB6A cells, the hybridoma cells aggluti- 
nated during the incubation period. This agglutination might 
conceivably have influenced adhesion by reducing the num- 
ber of single hybridoma cells available for interaction with 
hepatocytes. To overcome this problem, the cells were prein- 
cubated at 20 rather than 37°C and also allowed to settle on 
the hepatocytes at 20°C for 15 min before incubation at 37°C. 
Under these conditions agglutination was absent or negligi- 
ble during the following hour•  Yet,  a  similar inhibition of 
adhesion  was  observed,  down  to  30%  of control  values 
(20-40 % of added cells) with a concentration dependence 
comparable to that seen with MB6A cells (Fig.  2). 
In addition to anti-T200,  antibody M5/49 (43) was used as 
a control. Both antibodies did not influence adhesion. M5/49 
is also a rat IgG2a and reacts with Thy.1,  which is approxi- 
mately equally  abundant  on  TAM2D2  cells  as  T200  and 
LFA-1  (see below). Further  evidence against agglutination 
being the cause of inhibition was the effect of Fab fragments 
(see below)• Agglutination occurred with most but not all of 
a set of T cell hybridomas (31) tested, independent of adhe- 
siveness and invasive potential. 
Effect of  Fab Fragments 
The effect of monovalent M17/4 anti-LFA-1 Fab fragments on 
adhesion of MB6A and TAM2D2 cells in a representative ex- 
periment is shown in Fig.  3.  Maximal inhibition,  "~50%, 
was seen at 10 I~g/ml, a much higher concentration than with 
whole antibody. Half-maximal inhibition occurred at differ- 
ent  concentrations  for  the  two  cell  types:  3.5  ~tg/ml  for 
TAM2D2 and  1.5  rtg/ml for MB6A cells.  In some experi- 
ments cells were only preincubated and antibody or Fab frag- 
ments were not present in the incubation medium. As shown 
in Table I, preincubation only with the Fab fragments did not 
lead to inhibition. With whole anti-LFA-1 antibody the effect 
was reduced as compared with when the antibody had been 
continuously present. 
Effect of  Anti-LFA-1 on Invasion 
The effect of antibodies on adhesion as well as on invasion 
was  also  determined  by counting  adherent  and  infiltrated 
cells  in  sections  of embedded  cultures.  The  observation 
period was usually extended to 4 h to allow for extensive in- 
vasion of the cells into the hepatocyte cultures. Both adhe- 
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Figure 3. Effect on adhesion of anti-LFA-1 Fab fragments. (Closed 
circles) TAM2D2 cells; (open circles) MB6A cells. 
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Antibody Compared with Preincubation Only 
Adhesion (% of control) 
Concentration  Continuous presence  Preincubation only 
lt  g /ml 
Anti-LFA-1  0.16  36.7  +  1.2  64.1  +  1.4 
antibody  0.08  60.3  4-  3.3  87.1  4- 0.7 
Anti-LFA-1  20  44.5  +  2.9  102.4  4-  1.3 
Fab  10  55.8  4- 4.0  101.0  +  2.5 
5tCr-labeled  TAM2D2 cells were preincubated with anti-LFA-1 antibody or 
Fab fragments at the indicated concentrations. The cells were then added to 
hepatoeyte cultures either in the preincubation medium or in fresh medium 
without antibodies (for details see Materials and Methods). The amount of 
label  attached to the hepatocytes was compared with that in control cultures 
(cells not exposed to antibody). The data given are from one of two experi- 
ments with identical  results. 
sion and invasion of MB6A as well as TAM2D2 cells were 
strongly inhibited. The effect was similar for both cell types 
although agglutination occurred with TAM2D2 and not with 
MB6A cells. The results of a representative experiment with 
TAM2D2 cells are shown in Fig. 4. Reduction of adhesion 
was larger than seen with radiolabeled cells, down to 20% 
of controls. This was not due to the difference in incubation 
period, because a similar reduction of the interaction index 
was also seen in cultures fixed after 1 h. It should be noted 
that this assay ignores all tumor cells present that do not 
really adhere to viable hepatocytes.  Furthermore,  the cul- 
tures are very extensively washed during dehydration, and 
the culture fragments centrifuged, possibly resulting in more 
extensive detachment of weakly adherent cells.  As can be 
seen in Fig. 4, invasion was sometimes reduced to a larger 
extent than adhesion. However, in most experiments the per- 
centages of inhibition were comparable. Reduction of inva- 
sion can therefore largely be attributed to the interference 
with adhesion to the upper surface of the hepatocytes, the ini- 
tial step in the invasion process. 
Binding of  Antibodies and Fab Fragments 
to Tumor Cells 
Scatchard plots  of binding  data obtained with  ~25I-labeled 
anti-LFA-1  antibodies  for MB6A  and  TAM2D2  cells  are 
,.o0,( ~  oi .o..o. )  IT  T 
,ool  :If  li 
'°I  "  TI 
40 
,o~ i  i 
2.5  1,iS  0.63  0.32  0,16  0,08  0.04  O,0l 
anII-LFA-1  ( pg/ml  ) 
Figure 4. Inhibition of adhesion and invasion of TAM2D2 cells in 
hepatocyte cultures 4 h after addition of the cells as determined by 
counting cells in sections of embedded cultures (see Materials and 
Methods). (Open circles) The interaction index and (closed  circles) 
the infiltration index (for explanation see Materials and Methods), 
as percentage of control values. Shown are the data for one of sev- 
eral experiments with similar results. 
shown in Fig.  5.  The dissociation constant calculated from 
the two plots was 0.93  x  10  -9 M or 1.06  x  10-9 M, respec- 
tively, and the calculated numbers of LFA-I molecules per 
cell were 4  x  104 for MBtA and 4  x  105 for TAM2D2. 
Binding was also assessed indirectly using 125I-labeled anti- 
rat IgG as  secondary antibody.  This yielded  a  saturation 
curve, which was converted into a  straight line by plotting 
1/cpm vs.  1/concentration, as shown in Fig. 6 for TAM2D2 
cells. The dissociation constant, as deduced from the inter- 
cept with  the x-axis,  was  1.03  x  10-9 M,  essentially the 
same value as measured directly. The  10-fold difference in 
LFA-1 density was in reasonable agreement with the 18 times 
lower amount of LFA-1  immune precipitated from MBtA 
cells:  340 cpm as compared with 6,200 cpm per  106 cells 
iodinated under the same conditions (Fig.  7). 
Binding of  Fab fragments was only assessed by the indirect 
method (not shown), because for unknown reasons very high 
nonspecific  binding  occurred  with  125I-labeled Fab  frag- 
ments. The dissociation constant was estimated to be 0.71  x 
10  -8 M. In this case binding was also measured by fluores- 
cence on the fluorescence-activated cell sorter (not shown). 
This  yielded  a  dissociation  constant  of 0.80  x  10  -s  M. 
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Figure  5.  Scatchard  plots  obtained 
with  125I-labeled  anti-LFA-1  anti- 
bodies  (specific activity:  3.3  x  10 l° 
cpm/mg  =  5  x  1012 cpm/gmol) for 
4  x  lO  s MBtA cells (lej~)  and 1.7  x 
l0  s TAM2D2 cells (right). 
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Figure 6.  Binding of anti-LFA-1 antibody  to 2  x  1@ TAM2D2 
cells, as determined by an indirect assay. Cells were exposed to vari- 
ous  concentrations  of antibody  and  then  to  ~25I-labeled anti-rat 
IgG. The saturation curve obtained was converted to a straight line 
by plotting 1/cpm vs. 1/concentration of antibody. Dissociation con- 
stants and binding levels were derived  from such plots and com- 
pared  for anti-LFA-1 and the control antibodies  (Table II). 
Thus, the dissociation constant of Fab fragments was approx- 
imately eight times larger than that of whole antibody. Since 
the two control antibodies against T200 and Thy.1  were of 
the same isotype as the one against LFA-1, it was possible to 
compare binding  to  these  three  molecules by the  indirect 
method. Table II gives the results. It is evident that both the 
extent of binding and the affinity of the control antibodies is 
at least comparable to anti-LFA-1. 
Discussion 
A  monoclonal antibody against LFA-1 was found to inhibit 
adhesion of highly malignant MB6A lymphoma and T  cell 
hybridoma cells to the upper surface of hepatocyte mono- 
layers and  thus  to  reduce  invasion into  those monolayers, 
whereas appropriate control antibodies had no effect. Since 
these highly  invasive cells readily form metastases, in the 
liver and spleen for MB6A cells (8) and both in the liver and 
many other sites for the T cell hybrids (30), and since nonin- 
vasive hybrids do not metastasize, this finding indicates an 
involvement of LFA-1 in the formation of liver metastases. 
LFA-1 is known to be involved in multiple cellular interac- 
tions, mainly between leukocytes (6,  11,  14,  15,  23, 26,  33, 
34, 42), and in some cases also between leukocytes and en- 
dothelial cells (4, 20, 47). Cytotoxic T lymphocyte killing of 
fibroblastic or epithelial target cells was found to be LFA-1 
independent  (40).  We were therefore surprised to find that 
LFA-1 is necessary for efficient adhesion to an epithelial cell. 
Apparently, the hepatocyte expresses an LFA-1 counterstruc- 
Figure 7. SDS-PAGE patterns 
of anti-LFA-1 immune precip- 
itates from 3.3  x  10  6 MB6A 
(left)  and  TAM2D2  (right) 
cells. 
ture (17) and in this respect may be unique among epithelial 
cells. If so, this might be one of the reasons for the predilec- 
tion of many lymphoma cells for the liver (2). For instance, 
the  MB6A  cells used here metastasize only to  spleen and 
liver (8). Recently a putative human LFA-1 counterstructure 
termed  ICAM-1  (35)  was  identified.  This  molecule  was 
shown not to be present on human hepatocytes (9). If human 
and  rat  hepatocytes  are  comparable  in  this  respect,  our 
results  suggest that more than one LFA-1 counterstructure 
exists. 
Our experiments were hampered by anti-LFA-l-induced 
agglutination of the T  cell hybridoma cells, a phenomenon 
not described for other cell types (6). On the contrary, anti- 
LFA-1 has been reported to inhibit spontaneous (21, 26) and 
12-O-tetradecanyl  phorbol-13-acetate  (TPA)-induced  (34) 
aggregation of lymphoblastoid cell lines. Inhibition of adhe- 
sion was not the trivial result of agglutination because in 1-h 
tests the effect persisted under conditions where agglutina- 
tion was minimal. In the 4-h tests performed to measure inva- 
sion, agglutination could not be avoided, but was probably 
not of influence because the effect was completely compara- 
ble  for MB6A  lymphoma cells which  did  not  agglutinate. 
Furthermore,  monovalent Fab fragments also inhibited but 
did not induce agglutination. The concentration required was 
much higher than that of whole antibody but this can be at- 
tributed to the measured eightfold lower affinity of the Fab 
fragments, as also demonstrated by the lack of inhibition if 
cells were only pretreated,  so that the Fab fragments were 
not present during the interaction period (Table I). 
It is remarkable that the two control antibodies directed 
Table 1I. Affinity and Binding Levels of  Antibodies 
Maximal binding 
Ko  TAM2D2  MB6A  TAM2D2/MB6A 
M  105 cpm/105 cells  105 cpm/lO 6 cells  105 cpm/105 cells 
Anti-LFA-1  (M17/4)  1  x  10  °9  2.87  0.33  8.7 
Anti-T200  (M1/9.3)  1  x  10  -9  2.76  0.42  6.4 
Anti-Thy.l  (M5/49)  4  x  100 ~0  2.59  -  - 
Cells were exposed to the indicated antibodies at various concentrations, and subsequently ~251-1abeled  anti-rat IgG, as detailed in Materials and Methods.  From 
plots as in Fig. 6, maximal binding at saturating antibody concentrations and the half-maximal binding concentration were derived, and from the latter value the 
dissociation constant was calculated. 
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although they were of the same isotype, had at least similar 
affinity, and exhibited similar binding levels. Apparently,  the 
interaction  of the anti-LFA-1  antibody with the cells is quali- 
tatively  different from the control antibodies. The reason for 
this remains unexplained. Recently, it was shown that bind- 
ing of particular anti-LFA-1  antibodies can activate cells. On 
B-cells  the effect was similar to that of B-cell  stimulatory 
factor-1 (24), and in T-cells proliferation and interleukin re- 
lease was induced (27),  implying that LFA-1 is a receptor 
able to transduce  signals into the cell. The induction of ag- 
glutination  might conceivably  be due to the generation of 
such a signal. 
The extent of adhesion of TAM2D2 and MB6A cells to he- 
patocytes  varied considerably between experiments but was 
roughly comparable for the two cell types (20-40 and  15- 
30% of added cells in 1 h, respectively). The extent of inhibi- 
tion of adhesion by anti-LFA-1  antibody was also similar or 
only slightly larger for TAM2D2 cells and independent of the 
extent of adhesion in individual experiments. This similarity 
is remarkable  in view of the 10-fold higher LFA-1 density on 
the TAM2D2 cells. Apparently,  there is no relation between 
the  amount  of  free  surface  LFA-1 and  LFA-l-dependent 
adhesion. This was also found for a series of different T cell 
hybridomas (data not shown). 
This lack of correlation has also been reported  for other 
cell types. For instance, cytotoxic macrophages require LFA- 
1 for enhanced adhesion to tumor target cells, yet express as 
much LFA-1 as endotoxin-primed macrophages, which are 
not cytotoxic and do not exhibit enhanced adhesion (44, 45). 
The tumor promoter TPA induces this enhanced adhesion to 
target cells (41) as well as LFA-l-dependent aggregation  of 
lymphoblastoid ceils (34) while it does not alter LFA-1 ex- 
pression. This suggests that LFA-1 function depends on the 
activity of signal transmission components like protein ki- 
nase C, the TPA receptor (25). LFA-1 belongs to a family of 
protein dimers that share a common I~-chain, one of which 
is  the  C3bi-receptor  (13, 37)  involved  in  phagocytosis  of 
C3bi-coated particles by macrophages (10). A similarity with 
LFA-1 is that this function of the receptor is not simply de- 
pendent  on  its  presence:  phagocytosis  occurs  only  when 
macrophages are activated (10). Furthermore, like LFA-I-de- 
pendent adhesion in lymphoblastoid cells and macrophages, 
phagocytosis  can be induced by TPA (48).  This similarity 
suggests that both the C3bi-receptor and LFA-1 interact with 
the cytoskeleton, and that this interaction  is directly or in- 
directly regulated  by protein kinase C.  Further  support  for 
this  notion is the phagocytosis  of anti-LFA-1--coated  lipo- 
somes by lymphocytes  (46).  Since cytoskeletal activity re- 
quires physiological temperatures,  this suggestion would ex- 
plain why LFA-l-dependent adhesion does not occur in the 
cold  in  contrast  to  CD2-  and  LFA-3-dependent  adhesion 
(39). An attractive possibility is that binding of LFA-1 to its 
counterstructure  induces the spreading of lymphoma cells on 
the  hepatocyte  upper  surface,  thus  increasing  the  surface 
area and hence the strength of adhesion. This possibility is 
now being studied. 
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